FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression - Forbes https://t.co/oeTWcPYjd2
— IDRO (@IDROOhio) March 10, 2019
from Twitter https://twitter.com/IDROOhio
March 09, 2019 at 10:01PM
Sunday, March 10, 2019
FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression - Forbes https://t.co/oeTWcPYjd2
from Twitter https://twitter.com/IDROOhio
March 09, 2019 at 10:01PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment